Inventor · disambiguated record
Jesse Jerome Smith
Also filed as: SMITH JESSE · SMITH JESSE J · SMITH JESSE JEROME
1 granted patent·11 pending applications·0 citations·filing 2010–2024
13Inventor score
Files withEPIZYME INC5OMEGA THERAPEUTICS INC4FLAGSHIP PIONEERING INNOVATIONS V INC1REMIX THERAPEUTICS INC1UNIV VANDERBILT1
Top patents by PatentIndex Score
12 records- 0170US2022160721A1Methods of treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 0263US2020323865A1Methods of treating cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 0361US2023046656A1Crebbp related cancer therapyEPIZYME INC·Filed 2022·Application pending·0 cites
- 0457US2019038633A1Methods of treating cancerEPIZYME INC·Filed 2017·Application pending·0 cites
- 0556US2024344061A1COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4alpha) GENE EXPRESSIONOMEGA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0652US2024018522A1Oligonucleotides useful for modulation of splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0746US11987791B2Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expressionOMEGA THERAPEUTICS INC·Filed 2020·Granted May 21, 2024·0 cites·37 claims
- 0845US2023374549A1Compositions and methods for inhibiting the expression of multiple genesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 0941US2022288237A1Compositions and methods for modulating apolipoprotein b (apob) gene expressionOMEGA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1040US2019270797A1Crebbp related cancer therapyEPIZYME INC·Filed 2017·Application pending·0 cites
- 1130US2011097423A1Gene Prognosis Predictor Signature for Colorectal CarcinomaUNIV VANDERBILT·Filed 2010·Application pending·0 cites
- 1230US2022348893A1Methods and compositions for modulating frataxin expression and treating friedrich's ataxiaOMEGA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jesse Jerome Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →